Previous 10 | Next 10 |
home / stock / wsnaf / wsnaf news
Concurrently, the Company is launching a non-brokered private placement NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CHICAGO and TORONTO, April 18, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana...
Wesana Health CEO Daniel Carcillo provides a preview of their upcoming presentation at NobleCon18 NobleCon18 - Noble Capital Markets 18th Annual Small and Microcap Investor Conference - April 19-21, 2022 - Hard Rock, Hollywood, FL 100+ Public Company Presentations | Scheduled Breakouts | Panel...
CHICAGO and TORONTO, March 29, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care pa...
CHICAGO and TORONTO, March 22, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF) , a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care p...
CHICAGO and TORONTO, March 14, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care pa...
CHICAGO and TORONTO, March 11, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care pa...
CHICAGO and TORONTO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF) , a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care pa...
Wesana’s novel and proprietary depression treatment protocol that includes a single high dose of psilocybin followed by a maintenance regimen of a microdose of psilocybin combined with cannabidiol, significantly reduced depressive behaviors in a validated animal model A singl...
Wesana granted pre-IND meeting with FDA, currently set for March 11, 2022 Wesana Clinics exhibited a record quarter of billings, new patient visits, telemedicine utilization, overall patient appointments, and ketamine administrations New flagship clinic set to open in la...
CHICAGO and TORONTO, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF) , a data driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care pa...
News, Short Squeeze, Breakout and More Instantly...
Wesana Health Holdings Inc Com Company Name:
WSNAF Stock Symbol:
OTCMKTS Market:
Wesana Health Holdings Inc Com Website:
Chicago, Illinois and Toronto, Ontario--(Newsfile Corp. - November 28, 2023) - Wesana Health Holdings Inc. (CSE: WESA.X) (OTCQB: WSNAF) (the " Company "), announced the execution of a Confidential Settlement and Release Agreement ("Settlement Agreement") between Wesana Health Clinic...
CHICAGO and TORONTO, July 05, 2023 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“ Wesana ” or the “ Company ”) ( CSE:WESA; OTCQB:WSNAF ), today announced the successful closing of the sale by Wesana Health Inc. (“WHI”), a subsidiary of...
CHICAGO and TORONTO, June 09, 2023 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“ Wesana ” or the “ Company ”) ( CSE: WESA; OTCQB: WSNAF ), today announced that all matters put forward at the Company’s annual general and special meeting (the ...